Tag Archives: Infant

Sobi buys rights to AstraZeneca infant drug for $1.5 billion upfront

FILE PHOTO: A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble LONDON (Reuters) – AstraZeneca (AZN.L) has taken another step to refocus on priority drugs by selling U.S. rights to a treatment for infant lung infections to Swedish Orphan Biovitrum (SOBIV.ST) for an upfront fee of $… Read More »